UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.039

Sortiert nach

Diagnosing Cystic Fibrosis in Adults

Seminars in respiratory and critical care medicine, 2023-04, Vol.44 (2), p.242

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Ivacaftor in Patients With Cystic Fibrosis Who Carry the G551D Mutation and Have Severe Lung Disease

Chest, 2014-07, Vol.146 (1), p.152-158

2014

Link zum Volltext

Verfügbarkeit prüfen

Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy

Breathe (Lausanne, Switzerland), 2021-12, Vol.17 (4), p.210112-210112

2021

Link zum Volltext

Verfügbarkeit prüfen

First occurrence of the genus Pleurobranchaea Leue, 1813 (Pleurobranchida, Nudipleura, Heterobranchia) in British waters, with the description of a new species

Zoosystematics and Evolution, 2024-01, Vol.100 (1), p.49-59

2024

Link zum Volltext

Verfügbarkeit prüfen

Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools

Heliyon, 2023-11, Vol.9 (11), p.e21861-e21861, Article e21861

2023

Link zum Volltext

Verfügbarkeit prüfen

Cast no shadow: assessing the disease-modifying effects of elexacaftor/tezacaftor/ivacaftor

The European respiratory journal, 2023-12, Vol.62 (6), p.2302026

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of credit constraints on rural household technical efficiency: Evidence from a city in northern China

China agricultural economic review, 2014-01, Vol.6 (4), p.654-668

2014

Link zum Volltext

Verfügbarkeit prüfen

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes

The New England journal of medicine, 2021-08, Vol.385 (9), p.815-825

2021

Link zum Volltext

Verfügbarkeit prüfen

Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world - opportunities and challenges

Current opinion in pulmonary medicine, 2021-11, Vol.27 (6), p.554

2021

Link zum Volltext

Verfügbarkeit prüfen

Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM

Drugs (New York, N.Y.), 2023-12, Vol.83 (18), p.1699-1707

2023

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on liver tests at a large single adult cystic fibrosis centre

Journal of cystic fibrosis, 2023-03, Vol.22 (2), p.256-262

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of credit constraints on rural household technical efficiency

China agricultural economic review, 2014-10, Vol.6 (4), p.654-668

2014

Link zum Volltext

Verfügbarkeit prüfen

Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?

Thorax, 2015-07, Vol.70 (7), p.615-616

2015

Link zum Volltext

Verfügbarkeit prüfen

Neurovascular complications post bronchial artery embolisation in patients with cystic fibrosis. A 7-year single centre retrospective review

Journal of cystic fibrosis, 2024-01, Vol.23 (1), p.165-168

2024

Link zum Volltext

Verfügbarkeit prüfen

Isolation of Exophiala dermatitidis is not associated with worse clinical outcomes during acute pulmonary exacerbations in cystic fibrosis

Journal of medical microbiology, 2022-05, Vol.71 (5)

2022

Link zum Volltext

Verfügbarkeit prüfen

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Journal of cystic fibrosis, 2019-09, Vol.18 (5), p.700-707

2019

Link zum Volltext

Verfügbarkeit prüfen

Ivacaftor for cystic fibrosis

BMJ (Online), 2018-05, Vol.361, p.k1783

2018

Link zum Volltext

Verfügbarkeit prüfen

After the Celebrations: Lessons from the New Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy

Annals of the American Thoracic Society, 2019-02, Vol.16 (2), p.189-190

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis

Journal of cystic fibrosis, 2023-09

2023

Link zum Volltext

Verfügbarkeit prüfen

Coordinated financial statements: what-is, what-if and how-much questions

Agricultural finance review, 2022-01, Vol.82 (1), p.133-150

2022

Link zum Volltext

Verfügbarkeit prüfen

Highlights from the 30th North American Cystic Fibrosis Conference, Orlando 2016

Paediatric respiratory reviews, 2018-03, Vol.26, p.1-3

2018

Link zum Volltext

Verfügbarkeit prüfen

Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis

Journal of cystic fibrosis, 2023-11

2023

Link zum Volltext

Verfügbarkeit prüfen

New and Emerging Treatments for Cystic Fibrosis

Drugs (New York, N.Y.), 2015-07, Vol.75 (11), p.1165-1175

2015

Link zum Volltext

Verfügbarkeit prüfen

CFTR modulator therapy in patients with cystic fibrosis and an organ transplant

Paediatric respiratory reviews, 2018-06, Vol.27, p.6-8

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.039

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.589)
Mit Volltextzugriff
(3.539)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.681)
Life Sciences & Biomedicine
(2.149)
Humans
(1.726)
Female
(1.013)
Male
(973)
Biological And Medical Sciences
(765)
Medical Sciences
(607)
Middle Aged
(607)
Adult
(535)
Aged
(520)
Animals
(462)
Physical Sciences
(405)
General & Internal Medicine
(268)
Cardiovascular System & Cardiology
(231)
Risk Factors
(231)
Adolescent
(220)
Treatment Outcome
(194)
Cardiac & Cardiovascular Systems
(193)
Fundamental And Applied Biological Sciences. Psychology
(193)
Medicine, General & Internal
(185)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Diagnosing Cystic Fibrosis in Adults

Effects of Ivacaftor in Patients With Cystic Fibrosis Who Carry the G551D Mutation and Have Severe Lung Disease

Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy

First occurrence of the genus Pleurobranchaea Leue, 1813 (Pleurobranchida, Nudipleura, Heterobranchia) in British waters, with the description of a new species

Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools

Cast no shadow: assessing the disease-modifying effects of elexacaftor/tezacaftor/ivacaftor

Effects of credit constraints on rural household technical efficiency: Evidence from a city in northern China

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes

Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world - opportunities and challenges

Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on liver tests at a large single adult cystic fibrosis centre

Effects of credit constraints on rural household technical efficiency

Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?

Neurovascular complications post bronchial artery embolisation in patients with cystic fibrosis. A 7-year single centre retrospective review

Isolation of Exophiala dermatitidis is not associated with worse clinical outcomes during acute pulmonary exacerbations in cystic fibrosis

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Ivacaftor for cystic fibrosis

After the Celebrations: Lessons from the New Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy

Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis

Coordinated financial statements: what-is, what-if and how-much questions

Highlights from the 30th North American Cystic Fibrosis Conference, Orlando 2016

Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis

Cardiopulmonary Exercise Testing Provides Prognostic Information in Advanced Cystic Fibrosis Lung Disease

New and Emerging Treatments for Cystic Fibrosis

CFTR modulator therapy in patients with cystic fibrosis and an organ transplant

Suchergebnisse filtern